4,7,10,13-eicosatetraynoic acid has been researched along with thromboxane b2 in 1 studies
| Studies (4,7,10,13-eicosatetraynoic acid) | Trials (4,7,10,13-eicosatetraynoic acid) | Recent Studies (post-2010) (4,7,10,13-eicosatetraynoic acid) | Studies (thromboxane b2) | Trials (thromboxane b2) | Recent Studies (post-2010) (thromboxane b2) |
|---|---|---|---|---|---|
| 11 | 0 | 0 | 7,483 | 715 | 485 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sankarappa, SK; Sprecher, H; VanRollins, M; Wilhelm, TE | 1 |
1 other study(ies) available for 4,7,10,13-eicosatetraynoic acid and thromboxane b2
| Article | Year |
|---|---|
Selective inhibitors of platelet lipoxygenase: 4,7,10,13-eicosatetraynoic acid and 5,8,11,14-henicosatetraynoic acid.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; 5,8,11,14-Eicosatetraynoic Acid; Arachidonic Acids; Blood Platelets; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Dose-Response Relationship, Drug; Fatty Acids, Unsaturated; Humans; Lipoxygenase Inhibitors; Structure-Activity Relationship; Thromboxane B2 | 1981 |